BDBM233382 US9346829, 20

SMILES: CN1[C@H]2COC[C@@H]1C[C@@H](C2)NC(=O)c1cn(-c2cccnc2C)c2ccccc12

InChI Key: InChIKey=YYNMAWNXIUMHBA-NNZMDNLPSA-N

Data: 1 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 233382   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
5-hydroxytryptamine receptor 3A (Homo sapiens (Human))	BDBM233382 (US9346829, 20) Show SMILES CN1[C@H]2COC[C@@H]1C[C@@H](C2)NC(=O)c1cn(-c2cccnc2C)c2ccccc12 Show InChI InChI=1S/C23H26N4O2/c1-15-21(8-5-9-24-15)27-12-20(19-6-3-4-7-22(19)27)23(28)25-16-10-17-13-29-14-18(11-16)26(17)2/h3-9,12,16-18H,10-11,13-14H2,1-2H3,(H,25,28)/t16-,17-,18+	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.5	n/a	n/a	n/a	n/a	n/a	37
Takeda Phamaceutical Company Limited US Patent					Assay Description The 5-HT3 antagonist activity of the compounds of the invention was determined by measuring the ability of the compounds to inhibit the calcium flux ...				US Patent US9346829 (2016) BindingDB Entry DOI: 10.7270/Q2MK6BRB
					More data for this Ligand-Target Pair